|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1400 I Street NW |
Address2 | Suite 1200 |
| City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401106380-51237
|
||||||||
|
6. House ID# 454430001
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Abyot Wondimu |
Date | 4/21/2026 12:02:40 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Lobbying Report: January 1st - March 31st, 2026 (Action Fund)
Federal (under tobacco issue code)
Legislation:
H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act
H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act)
H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act
H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act)
H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act
FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act
FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act
FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act
FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act
FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act
S. 4257 Resources to Prevent Youth Vaping Act
H.R. 7567 Farm, Food, and National Security Act of 2026
H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Issues:
CDC tobacco prevention and cessation programs and funding
Congressional Caucus to End Youth Vaping
FDA authority over tobacco products
Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes
CDC Chronic disease prevention programs
FDA enforcement against unauthorized tobacco products
FDA review of flavored e-cigarettes
FDA oversight of nicotine pouches
Tobacco Harm Reduction Caucus
Agencies Visited:
Food and Drug Administration
US House of Representatives
US Senate
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brian J |
Hickey |
|
Sen. Dick Durbin
Leg. Asst. for Hlth Policy & Soc. Sec.
2007-2009
Senate Dem. Policy Comte.
Policy Adv.
2002-2007
Sen. Edward Kennedy (Hlth, Educ. and Pensions Cmte.
2001-2002 |
|
Luke C. |
George |
|
Congressman Martin Frost
Legislative Assistant and Systems Manager
April 2003 to January 2005
Congressman Lloyd Doggett
Legislative Assistant and Systems Manager
January 2005 to July 2007
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
GHAI Overdose Initiative (under healthcare issue code):
Legislation:
FY 26 Appropriations bills
Modernizing Opioid Treatment Access Act
PEER Support Act
H.R. 5420 - Workplace Overdose Reversal Kits to Save Lives Act
S.3522 - No Red Tape For Addiction Treatment Act
S. 1165/H. R. 2586, Reentry Act
S. 1720/H.R. 1510, Due Process Continuity of Care Act
S. 2697, Due Process Continuity of Care Act
SUPPORT for Patients and Communities Reauthorization Act
Issues:
Medicaid prior authorization requirements
Access to medications for opioid use disorder
Overdose prevention
Racial disparities in overdose deaths
Financing (grants) for behavioral health care services and programs
Agencies Visited:
Centers for Disease Control and Prevention
US House of Representatives
US Senate
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Jones |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: https://www.tobaccofreekids.org/
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
| Tobacco-Free Kids Action Fund |
|
|
||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |